Speaker

Local Speakers

Dr. Mohamed Abuelkhair

Chief Executive Officer
Al Thiqa Pharmacy
Abu Dhabi, UAE

Dr. Mohamed Abuelkhair

Dr. Mohammed Abuelkhair got his undergraduate and graduate degree in Clinical Pharmacy from Creighton University in the United State, in addition to the US federal Clinical Leadership institute. He has 21 years of Pharmacy experience as registered pharmacist in Ohio, Nebraska, Texas and licensed in KSA and UAE. He was the winner of the Scissor and Hammer Awards from the United State Vice presidents as a consultant member of the VA Pharmacy Benefit Management team. Dr. Abuelkhair served as clinical faculty in Ohio State University and the University of Mississippi as assistant professor of clinical pharmacy. He founded the International Muslim pharmaceutical organization in the Washington in 1997 and established ASHP Accredited Pharmacy Practice Residency Program in Columbus, Ohio. He was the acting director of Pharmacy at King Faisal specialist Hospital in Jeddah. He established HAAD Drugs and Medical products department and the Drug information and poison control center in Abu Dhabi. He chairs several committees including: Abu Dhabi Pharmacy And therapeutics Committee; Alternative and complementary Medicine committee, Pharmacy Council, Vaccine committee, and Allergy and asthma committee. Dr. Abuelkhair won the prestigious Arab Health Award in 2005 for excellence in pharmacy services. His major area of research interest is in Drug safety and Therapeutic Drug Management and is a frequent speaker at national and international conferences.

Abrar Al Bakri

Pharmacist
Al Thiqa Specialty Pharmacy
Abu Dhabi, UAE

Abrar Al Bakri

Dedicated Clinical Pharmacist with diverse experience across hospital, specialty, and community pharmacy settings. Currently serving as a Patient Care Coordinator at Althiqa Specialty Pharmacy, providing specialty pharmacist services including care coordination, insurance navigation, financial support, and patient education. Active member of the Medical Outreach Team, strengthening collaborations with physicians and enhancing patient access to advanced therapies. Previously trained at Naser Institute Hospital, Cairo, gaining hands-on expertise in ICU, Hepatology, and Cardiology, with a focus on medication therapy management, pharmacotherapy optimization, and adverse event monitoring. Skilled in delivering medical education to healthcare teams and preparing patient case studies. Currently pursuing a Master’s in Clinical Pharmacy at Gulf Medical University in collaboration with Virginia Commonwealth University, building on a Bachelor’s in Clinical Pharmacy from Cairo University. Recognized for leadership, problem-solving, and research capabilities, with proficiency in evidence-based clinical decision-making, medication safety, and use of advanced drug information resources.

Dr. Abdullah Bani Irshaid

MBA,PhD

ACHC Int'l GCC & ME Managing Director Accreditation Commission for Health Care (ACHC) UAE

Dr. Abdullah Bani Irshaid

MBA,PhD

Dr. Abdullah Bani Irshaid is a seasoned healthcare and management leader with distinguished expertise in strategic operations, quality management, and international affairs. As Managing Director of the Accreditation Commission for Health Care (ACHC-USA) in the GCC and Middle East, and Founder of Ashore Consultancy for Health & Safety, he has guided organizations across Jordan, the UAE, and Saudi Arabia. Holding dual PhDs in Strategic Operations Management & International Affairs and in Quality Management, Dr. Bani Irshaid has led high-impact initiatives in healthcare accreditation, consulting, and training, advancing excellence and sustainability in regional health systems.

Dr. Adel El Assy

Senior Manager, Pharmaceuticals Supply Chain Management
M42, Abu Dhabi, UAE

Dr. Adel El Assy

Adel Al-Assy RPh is a seasoned pharmaceutical Revenue cycle, supply chain and procurement expert, currently serving as the Senior Manager of Pharmaceuticals Supply Chain Management at M42 in Abu Dhabi. With over a decade of experience in the healthcare industry, he has a proven track record of optimizing multi-million-dollar budgets, leading large-scale pharmaceutical tenders, and forging strategic partnerships with key industry stakeholders. Adel has also played a pivotal role in collaborating with health authorities to ensure medication availability across various healthcare settings. He holds an EMBA in Healthcare leadership, Bachelor’s degree in Pharmaceutical Sciences from the University of Alexandria and is a certified professional in revenue cycle and supply chain management.

Dr. Ahmad Chaker

R.Ph., EMBA, DPLA, BCSCP

Director of Ambulatory Pharmacy Cleveland Clinic Abu Dhabi

Dr. Ahmad Chaker

R.Ph., EMBA, DPLA, BCSCP

Ahmad Chaker is currently the Director of Ambulatory Pharmacy at Cleveland Clinic Abu Dhabi. Ahmad previously worked in multiple positions at Cleveland Clinic Abu Dhabi: Manager, Oncology Pharmacy Services; Manager, Sterile Preparation Center; Lead Pharmacist Automation; and Informatics. Before joining the Cleveland Clinic in Abu Dhabi, Ahmad worked at Al Mafraq Hospital in Abu Dhabi and The American Hospital in Dubai. He carries multiple certifications in the fields of sterile preparation, automation, project improvement, and leadership. Ahmad’s major areas of interest are process improvement, lean management, change management, sterile preparation compounding, pharmacy informatics, and automation. Ahmad has delivered multiple presentations and posters on sterile preparations, the clean room, automated dispensing cabinets, and pharmacy manpower benchmarks.

Dr. Antoine Arkieh

Consultant Endocrinologist, Imperial College
London Diabetes Center
Abu Dhabi, UAE

Dr. Antoine Arkieh

Consultant Endocrinologist: Imperial College London Diabetes Center, Abu Dhabi.
Former Assistant Professor of Medicine – Tulane University School of Medicine, New Orleans – USA
American Board Certified

Mr. Camille Harfouche

Director, Market Access and Alliance Management – Gilead Sciences
Dubai, UAE

Mr. Camille Harfouche

Camille Harfouche, Director Market Access and Alliance management at Gilead Sciences, brings 28 years of pharmaceutical industry experience across 18 MENA markets, leading diverse functions like marketing, access, medical, regulatory affairs, and commercial operations. He has contributed to over 50 product launches in rare diseases, oncology, virology, neurology and cardiometabolic areas. Camille is an expert in managed entry and value-based agreements and a speaker at global industry forums, like the World Pharma Pricing and Market Access Congress. He holds an MS in Biology, a degree in Agricultural Engineering, and an MBA.

Essam Thabet Yousef

Gulf, Market Access Lead – GSK
Dubai, UAE

Essam Thabet Yousef

Essam Yousef is a seasoned pharmaceutical leader with over 24 years of experience in the Gulf region, excelling in market access strategies, regulatory compliance, and stakeholder engagement. As Market Access Lead at GSK in Dubai, he drives product inclusion, fosters strategic partnerships, and enhances operational efficiency. Essam has expertise in managing diverse portfolios, including oncology and biologics, ensuring improved patient access and market success. Holding a B.Sc. in Pharmacy (2000), an MBA in International Management, and certifications in Health Economics and Project Management, he combines deep industry knowledge with strategic insight to advance healthcare access across the region.

Dr. James Zachariah Panakkal

Specialist Dermatology, Head of Dermatology and Cosmetology, Medeor Hospital
Abu Dhabi, UAE

Dr. James Zachariah Panakkal

Dr. James Zachariah Panakkal, Specialist Dermatologist and Head of the Department of Dermatology, Venereology and Cosmetology, has over 20 years of experience in Dermatology spanning India, the United Kingdom, Oman, and the UAE. He is a recipient of the Best Doctor Award for 2007 awarded in Buraimi from the Ministry of Health, Oman, for the services rendered in the health care field. He is a Board Member in Laser Surgery (ABLS) and Diploma Certified in Aesthetic Medicine (AAAM), a pioneer in the usage of biological medications and newer therapies for chronic intractable skin diseases, handling complicated skin conditions of both chronic and acute nature.

Dr. Hady Jerdak

Internal Medicine, Pulmonary Diseases, Sleep Disorders, Critical Care Consultant Harley Street Medical Center Abu Dhabi, UAE

Dr. Hady Jerdak

Dr. Hady started his education at the American University of Beirut (AUB) and finished his specialty in pulmonary diseases and sleep disorders in France at the University of Lille. He has a vast experience in Asthma, COPD and cancer of the lungs (diagnosis and management). He does flexible Bronchoscopies for the patients here at Harley Street Medical Centre. Dr. Hady is also a specialist in Sleep Disorders, Sleep Apnea, Insomnia, Narcolepsy, Pediatric Sleep Disorders and other problems that are sleep related. At Harley Street Medical Centre we have a fully fledged sleep lab where the patient can perform his/her sleep study in-house attended by a HAAD Licensed nurse.

Dr. Hassan Ali

Assistant Manager
Almadallah Healthcare Management
Dubai, UAE

Dr. Hassan Ali

A dedicated and experienced healthcare management professional with a proven history of enhancing customer satisfaction and business success. Dr. Hassan Ali has a strong background in medical claims and approvals, with leadership experience in managing large teams and optimizing operational efficiency. He is skilled in strategic planning and team development and has a strong focus on high-quality service and consistent results. With certifications in Lean Six Sigma Black Belt (LSSBB) and as a Certified Professional Coder (CPC), he brings a unique blend of clinical knowledge and process improvement expertise to any role. His professional journey includes roles from General Practitioner to Medical Claims & Approvals Assistant Manager, showcasing a career dedicated to improving healthcare services.

Dr. Haider Shamsi

Health Economist and HTA Specialist Department of Health – Abu Dhabi

Dr. Haider Shamsi

Haider Shamsi is a Health Economist and HTA Specialist at the Department of Health – Abu Dhabi, where he leads the development of evidence-based policies and value-driven reimbursement frameworks. His expertise spans economic modeling, cost-effectiveness analysis, and strategic market access for innovative therapies. Haider also brings clinical insight as a pharmacist, enhancing the integration of health economics into real-world care. Previously, he worked at the UK’s National Institute for Health and Care Excellence (NICE), contributing to technology appraisals for pharmaceuticals, medical technologies, and highly specialised therapies. He is passionate about advancing health policy, improving patient access, and driving sustainable healthcare systems.

Dr. Inas El-Najjar

Consultant Hematology & Cellular Therapy/Director of Postgraduate and Undergraduate training
Abu Dhabi Stem Cells Center
Abu Dhabi, UAE

Dr. Inas El-Najjar

Dr. El-Najjar is an astute practitioner and researcher with 20 years of extensive experience in both the UAE and the UK. She has held several prominent positions exemplifying her commitment to the highest standards of clinical excellence, including working as a Consultant Hematologist at the prestigious Guy’s and St. Thomas NHS trust in central London. Additionally, she served as an Honorary Consultant at King’s College London

Moreover, she has published several papers in peer-reviewed journals and presented at prominent international meetings, including the American Society of Hematology and the European Bone Marrow Transplant. As a further demonstration of her leadership capabilities, she served as the Lead Educational Supervisor for hematology core medical trainees at Guy's Hospital in partnership with the London Deanery. Dr. El-Najjar strives to provide patients with evidence-based hematology care in accordance with the latest research.

Dr. Islam Elkonaiss

MPharm PG Dip IP

Gulf Medical Lead Novartis and UKCPA Director
Dubai, UAE

Dr. Islam Elkonaiss

MPharm PG Dip IP

Islam Elkonaissi is an international speaker and a prescribing cancer pharmacist in the UK. He is a Director of the UK Clinical Pharmacy Association (UKCPA) and the Gulf Medical Lead for Hematology at Novartis Middle East. Islam graduated from University College London and held leadership roles at world-renowned institutions, including The Royal Marsden in London and Cambridge University Hospitals NHS Foundation Trust.

Mira Tamer

Clinical Strategy & Market Access Lead, Al Thiqa Pharmacy
Abu Dhabi, UAE

Mira Tamer

Mira Tamer is a pharmacist licensed in the U.K. and Germany with diverse experience across healthcare. A graduate of King’s College London, she began her career in community pharmacy before advancing as a clinical pharmacist at Cleveland Clinic London. Seeking broader exposure, she joined Johnson & Johnson in Germany as a sales specialist and later supported the Market Access team in Dubai. Bringing together insights from clinical practice, industry, and market dynamics, she now serves as Clinical Strategy & Market Access Lead at Al Thiqa Specialty Pharmacy, where she drives patient-focused solutions and stakeholder engagement.

Mr. Mohamed Abdelkader

Head of Market Access NearEast & UAE - Boehringer Ingelheim
Dubai, UAE

Mr. Mohamed Abdelkader

Mohamed Abdelkader is an accomplished pharmaceutical leader with over 20 years of multinational experience spanning the GCC, Levant, JENA, and African markets. Currently Head of Market Access for Boehringer Ingelheim NearEast–UAE Cluster, he leads strategic access, reimbursement, and value partnerships across UAE, Levant, Iran, and Pakistan. Previously with Janssen (Johnson & Johnson), he held senior roles including Country Management, Cluster Lead Health Economics & Market Access, and Strategic Account Head. Recognized for transformational leadership, Mohamed has launched innovative therapies, built sustainable healthcare partnerships, and developed future talents—bridging science, policy, and patient access across diverse geographies

Dr. Mohammad Yousuf Abdulfattah

Sheikh Shakhbout Medical City Abu Dhabi, UAE

Dr. Mohammad Yousuf Abdulfattah

I have got my Bachelor Degree in Pharmacy from Ajman University , then my Master degree in clinical pharmacy from Queens University –Belfast .
I joined Mafraq Hospital in 2009 , then Sheikh shakhbout medical city 2019.
Worked in many areas including Inpatient and Outpatient Pharmacy, Oncology pharmacy, Drug Information Centre , IBD centre , quality and medication safety ,with Clinical pharmacy department , involved in Pharmacy and therapeutics committee , OFF label medication, and leading the pharmacy education programme.

Dr. Mohamed Badr

Head of Operations – Health – UAE/GULF Dubai, UAE

Dr. Mohamed Badr

Dr. Mohamed Badr, with over 21 years of experience, is a distinguished professional in healthcare, insurance, and IT sectors, based in the GCC and Egypt. Renowned for operational excellence and customer-centric strategies, he excels in leading large teams to drive efficiency and enhance satisfaction within profitable frameworks. His expertise spans health insurance claims management, underwriting, quality and process management, technology integration, and project management. With a strong foundation in medicine and IT, Dr. Badr is adept at analyzing healthcare trends, mitigating fraud, and designing KPIs. His career is marked by strategic leadership, innovative solutions, and a commitment to excellence.

Dr. Mohamed Tannira

PhD Candidate, Health

Economics and Policy ISPOR UAE Chapter President Elect, Health Technology Assessment and Health Economics Senior Manager, MEAR Region at AbbVie Dubai, UAE

Dr. Mohamed Tannira

PhD Candidate, Health

Mohamed Tannira is an accomplished professional with extensive expertise in market access, health technology assessment (HTA), health economics and outcomes research (HEOR), and real-world evidence (RWE). With over 15 years of experience, Mohamed currently serves as the Senior Manager of HTA & HEOR for the Middle East, Africa, and Russia (MEAR) at AbbVie Biopharmaceuticals. In this role, he leads the development of strategic RWE and HEOR initiatives that drive market access and ensure optimal healthcare outcomes across the region. Previously, Mohamed held multiple leadership roles at AbbVie, including Eyecare, Hematology HEOR & HTA Lead in UK, and Senior Market Access Lead for the Gulf region. His experience also includes successfully leading initiatives in pricing, reimbursement, and value-based healthcare, contributing to transformative market access strategies in immunology, oncology, and other therapeutic areas. In addition to his current role, Mohamed is an Adjunct Clinical Professor at the University of Sharjah, where he co-teaches courses on clinical pharmacy, market access, and health economics. He is also actively engaged in various professional organizations, serving as President-elect of the UAE Chapter of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), and as a board member of the Emirates Health Economics Society. Mohamed holds a master's degree in health economics from Pompeu Fabra University and is currently pursuing a PhD in Health Economics and Policy at Lancaster University. His memberships include leadership roles in several industry workstreams, including the Regional PhRMA HT Workstream and the AbbVie Global HTA Workstream. His contributions to healthcare policy and his work in shaping HTA environments in the Middle East have earned him numerous awards and recognition. Mohamed is recognized for his ability to translate complex health economics concepts into actionable insights, making him a sought-after speaker at regional and international conferences.

Dr. Mona Thakre

Consultant Neurologist
Mediclinic Parkview Hospital
Dubai, UAE

Dr. Mona Thakre

Dr. Mona Thakre is a well experienced Neurologist with more than 20 years of experience to her credit in UAE and India. She had her basic MBBS and MD in medicine from Nagpur University, India and DM and DNB in Neurology from Bombay Hospital, Mumbai University, India. She has completed her Speciality Certificate in Neurology from Royal college of Physicians (UK) and is a Fellow of American Academy of Neurology(FAAN).

She has worked in Government hospital Rashid hospital as Senior Specialist for 10years and since last 7 years as Consultant and Head of Neuroscience department at Al Zahra Hospital which is a tertiary care hospital in Dubai. She is the elected Board member of Emirates Neurology Society. Her areas of interest: Multiple Sclerosis ,Headache Stroke, Epilepsy and Movement disorders. She is an active researcher and has numerous presentations in local and international conferences. She has published numerous papers in peer reviewed journals.

Dr. Mustafa Mukhtar

Operation Manager, Whealth International TPA Dubai, UAE

Dr. Mustafa Mukhtar

Dr. Mustafa Mukhtar is a seasoned professional in the health insurance industry with over seven years of experience. He has built a strong career across two leading Third-Party Administrators in the UAE, serving four years with Nas Neuron Healthcare Services and three years with Almadallah Healthcare Management. Dr. Mukhtar holds a master's degree in healthcare management and a PhD in Healthcare Insurance, combining academic excellence with practical expertise. His professional journey reflects a deep commitment to optimizing healthcare operations, approvals, and claims management, positioning him as a trusted leader in the healthcare insurance sector.

Prof. Dr. Nadia Rashed Al Mazrouei

PhD, MSc, F-FIP

Vice President, International Pharmaceutical Federation (FIP) | Fellow, FIP
President, Pharmacists Association – UAE | Associate Professor, University of Sharjah
Sharjah, UAE

Prof. Dr. Nadia Rashed Al Mazrouei

PhD, MSc, F-FIP

An Emirati pharmacy leader with 35+ years of transformative impact in clinical pharmacy, healthcare leadership, and global pharmaceutical policy. Elected Vice President of the International Pharmaceutical Federation (2025–2027) and awarded the prestigious FIP Fellowship (2025) for advancing pharmacy education, regulation, and practice worldwide. Currently President of the Pharmacists Association UAE, FIP EMR Forum, and ISPOR UAE Chapter, with extensive service in WHO Expert Committees. Associate Professor at University of Sharjah leading innovations in pharmacy education, pharmacoeconomics, digital health, and sustainability. Author of 60+ peer-reviewed publications, mentor, and advocate for women in science and pharmacy workforce development globally.

Dr. Najwa Al-Bustani

Consultant Neurologist Neurology, Neurological Institute
Cleveland Clinic Abu Dhabi

Dr. Najwa Al-Bustani

Dr. Najwa Al-Bustani, is a Neurology Consultant with special interest in Neuromuscular medicine and Neurology Residency program director in the Neurological Institute at Cleveland Clinic Abu Dhabi. She holds an academic position of a Clinical Assistant Professor of Medicine at Cleveland Clinic Lerner Collage of Medicine, Case Western Reserve University.

Dr. Al-Bustani received her medical degree from Sultan Qaboos University, Muscat, Sultanate of Oman. She completed her residency training in Neurology at McGill University, Montreal, Canada. Subsequently, she completed her fellowship in Clinical Neurophysiology, EMG Track, Neuromuscular Medicine at the University of Washington, Seattle, W.A., USA

Dr. Nigel Umar Beejay

Consultant Physician and Gastroenterologist, Emirates Hospital Dubai and Abu Dhabi UAE

Dr. Nigel Umar Beejay

Dr. Nigel Umar Beejay is a highly accomplished Physician Executive, Consultant Physician, Gastroenterologist, and Hepatologist with over 25 years of global healthcare experience. He currently practices with Emirates HealthCare in Dubai and Abu Dhabi, as well as on Harley Street, London. A graduate of King’s College, Cambridge University, Dr. Beejay holds advanced qualifications, including postgraduate studies in London, Boston University, and the University of Toronto, as well as degrees in Social and Political Sciences (Cambridge), Biomedical Informatics (Oregon Health Science University), and Medical Hypnosis (University College London).

Dr. Beejay has held notable positions, such as Chairman of Arab Health Gastroenterology in 2017 and 2018, and Chair of the Health Information Management Committee at Sheikh Khalifa Medical City in Abu Dhabi under Cleveland Clinic management. He was involved in the development of colon cancer screening guidelines in the United Arab Emirates. An active educator, he lectures internationally on topics including Gastroenterology, Health IT, Genomics, Quality, and Advanced Endoscopy.

He is affiliated with prestigious professional bodies, including the American College of Healthcare Executives, and holds fellowships with the American College of Physicians, the British Society of Gastroenterology, the American Gastroenterological Association, and the American Society of Gastrointestinal Endoscopy. Dr. Beejay’s dedication to clinical practice, education, and innovation has established him as a leader in his field.

Rafa Al Khalifa

R.Ph, B. Pharm, EMBA HCML

Associate Director of Specialty Pharmacy Services
Al Thiqa Specialty Pharmacy
Abu Dhabi, UAE

Rafa Al Khalifa

R.Ph, B. Pharm, EMBA HCML

Rafa Al Khalifa is a committed pharmacy professional with a strong dedication to specialty pharmacy, global health, and sustainable pharmaceutical practices. As the Associate Director of Al Thiqa Specialty Pharmacy Services, she plays a pivotal role in optimizing patient care, advancing pharmacy operations, and implementing innovative healthcare solutions. Her commitment to global health collaboration is evident in her role as the Lead of the IVPN Global Health Listserv, where she fosters knowledge exchange and strategic discussions among international healthcare professionals. Additionally, she serves as the Regional Representative of the Data and Intelligence Commission at the International Pharmaceutical Federation (FIP), contributing to data-driven decision-making and the advancement of pharmaceutical sciences worldwide. As the Social and Administrative Pharmacy Liaison for the FIP Early Career Pharmaceutical Group (ECPG), Rafa actively engages with emerging pharmacy professionals, advocating for their involvement in policy-making, pharmacy practice development, and research. Driven by a vision of sustainable healthcare, Rafa leads EcoRx, a pharmaceutical waste management initiative dedicated to reducing environmental impact while ensuring patient safety. With a background in pharmacy, executive healthcare management, and leadership, Rafa continues to make a meaningful impact in both national and international pharmaceutical landscapes.

Dr. Raya Zayadeen

MCP, MHQS, CPHQ, CPPS, CPHFH, BCPS

Vice President, Pharmacy and Therapeutics, Global Patient Care Platform,
UAE and Bahrain

Dr. Raya Zayadeen

MCP, MHQS, CPHQ, CPPS, CPHFH, BCPS

Raya Zayadeen is a healthcare executive with over 15 years’ leadership in pharmacy, medication safety, and quality improvement across leading healthcare systems in the UAE and Gulf. As Vice President of Pharmacy & Therapeutics at M42, she drives strategic transformation of pharmacy services spanning ambulatory, long-term care, maternity, and specialty facilities. She specializes in innovative models improving outcomes, patient safety, and financial efficiency. Raya holds an MSc in Clinical Pharmacy, an Executive MBA, and a Master’s in Healthcare Quality and Safety from Harvard Medical School. A CPHQ, CPPS, and BCPS, she is committed to advancing pharmacy as a pillar of patient-centered care.

Dr. Reem Hozayen

Procurement lead, Imperial College London Diabetes Centre
Abu Dhabi, UAE

Dr. Reem Hozayen

With over 15 years of experience across healthcare, supply chain, and medical insurance, Dr Reem Hozayen has built extensive expertise in managing both direct and indirect procurement. Having previously held key roles at AHS SEHA and NMC, she has developed a strong track record in sourcing, vendor management, and optimizing procurement processes to achieve efficiency and value. In addition, Dr Reem Hozayen has gained valuable patient experience at SEHA AHS clinics, giving her a unique perspective that bridges operational excellence with service quality in the healthcare sector.

Saad Sultan

PharmD

Executive Director, Pharmacy Services, Cleveland Clinic Abu Dhabi, UAE

Saad Sultan

PharmD

Saad Sultan, PharmD, is Executive Director of Pharmacy at Cleveland Clinic Abu Dhabi, a 405-bed quaternary care hospital affiliated with the Cleveland Clinic Foundation. With over 15 years of leadership experience, he oversees inpatient, ambulatory, specialty, retail, infusion, and home delivery services. He is committed to building a resilient pharmacist workforce, advancing clinical services, and creating safe, efficient medication-use systems. Previously in the U.S., he helped establish a central specialty pharmacy, directing prescriptions from 15 states to one hub and leveraging the 340B Drug Discount Program to expand access and ensure sustainability.

Dr. Salim Skafi

Gulf Market Access Director, AstraZeneca
Dubai, UAE

Dr. Salim Skafi

Biologics, Vaccine & Immune Business Unit and Biopharm Market Access Director, GCC Bachelor in Pharmacy - University of Jordan
25 years in Pharma industry, experience in multi-national corporations .
Held several roles and responsibilities in several markets across GCC and Levant.
Experienced in several functions across the pharmaceutical corporations; Commercial roles in sales & marketing, Corporate Affairs, Market Access & pricing .
Assumed several roles at regional & area levels; MEA commercial Director (2020-2022); Asthma strategy Director for International markets (2018-2020)

Dr. Sara Al Dallal

President of Emirates Health Economics Society
Dubai, UAE

Dr. Sara Al Dallal

Dr. Sara Al Dallal, the founder and president of the Emirates Medical Association’s Emirates Health Economics Society is a Medical Doctor graduated from the UAE University College of Medicine and Health Sciences. She completed her internal medicine residency in Dubai Health Authority, and she holds a master's in health care management from Royal Colleges of Surgeons Ireland and a double master's degree on Health Policy and Health Economics from London School of Economics. She is currently holding the position of Senior Health Service Specialist in Dubai Health Authority.

Dr. Shady Ashraf

Senior Team Leader, Abu Dhabi Unit, MedNet Global Healthcare Solutions LLC Dubai, UAE

Dr. Shady Ashraf

Dr. Shady Ashraf is a seasoned physician with over 15 years of experience in the medical insurance sector across the GCC. He holds a master’s in healthcare management from Swiss Business School, along with certifications from the Chartered Insurance Institute (UK), Harvard Business School, and AHIP. Dr. Ashraf has held key leadership roles at organizations including MedNet, Bupa Global, Noor Takaful, and Bupa Arabia, specializing in clinical audits, claims management, and healthcare operations.

Mr. Wasim Nashat Ibrahim

Pricing Excellence Lead – Sanofi Greater GCC Region
Dubai, UAE

Mr. Wasim Nashat Ibrahim

Professional Summary:
Currently serving as Pricing Excellence Lead at Sanofi for GCC
Over 20 years of pharmaceutical industry experience
Expertise in pricing strategy, market access, tender management, and health economics
Strong focus on Gulf and emerging markets

Key Qualifications:
MSc in International Health Technology Assessment (University of Sheffield, UK 2020-2023)
B.Sc. in Pharmacology (University of Auckland, New Zealand 1997-2002)

Career Experience:
Progressive roles at Sanofi, AbbVie, Takeda, and Abbott
Previous commercial role to leadership positions in Pricing and Market Access
Currently manages pricing strategies and value access for Greater Gulf Region

Yacine Amirouche

PharmD, MSC

Market Access Director, Novo Nordisk
Dubai, UAE

Yacine Amirouche

PharmD, MSC

Yacine is the Market Access Director of Novo Nordisk Pharma Gulf.
He is a pharmacist by training. He later pursued a master’s degree in Pharmaceutical Management in France, and another master’s degree in Health Economics in Spain.
Yacine’s journey with Novo Nordisk started in 2014, and has since occupied several roles in marketing, customer insights, public affairs and market access.
He has also worked with other multinational pharmaceutical and consulting companies specialized in healthcare.
Yacine has a broad experience in different healthcare systems by living and working in different geographies, including North Africa, France, Mexico, Denmark, UAE and the GCC region.

Dr. Yousra Kamal

R.PH,CPC

Pharmacy Claims Analyst, Cleveland Clinic Abu Dhabi
Abu Dhabi, UAE

Dr. Yousra Kamal

R.PH,CPC

Yousra Kamal, R.Ph. CPC, is a Claims Analyst managing Specialty Drugs approvals with over 10 years of experience in hospital, insurance, and community pharmacy practice. She currently serves at Cleveland Clinic Abu Dhabi, where she oversees a high-cost specialty medication portfolio exceeding AED 125 million annually. Her expertise lies in clinical validation, coding, payer negotiation, formulary management, and regulatory compliance, with a focus on facilitating patient access to advanced therapies. Yousra is committed to driving evidence-based, cost-effective patient care by integrating clinical knowledge with insurance processes, improving treatment continuity, and contributing to innovative models of specialty medication management

Zakieh Abuelkhair

RPh, MPBA

Director of Pharmacy Operations, Al Thiqa Pharmacy Group
Abu Dhabi, UAE

Zakieh Abuelkhair

RPh, MPBA

Zakieh Abuelkhair is the Director of Pharmacy Operations at Al Thiqa Pharmacy Group, where she founded and led the Specialty Pharmacy Division for complex conditions, spearheaded pharmacy-based vaccination centers, and advanced digital therapeutics with HTA approval.

She earned her Bachelor’s degree in Pharmacy from the University of Sharjah and a Master’s degree in Specialty Pharmacy Business Administration from the University of Pittsburgh.

In addition to her executive role, Zakieh is a faculty member at Al Ain University, teaching Pharmacoeconomics and Pharmaceutical Marketing to shape the future generation of pharmacy professionals.

Her mission is to reshape and elevate the role of Specialty Pharmacy across the region, championing preventive care, specialized services, and patient-focused digital health solutions.

Dr. Zeyad Elgamal

Founder of Tamrah Health
Abu Dhabi, UAE

Dr. Zeyad Elgamal

Zeyad Elgamal is a healthcare leader with over 20 years of experience spanning hospital and retail pharmacy, pharmaceutical industry, healthcare management, and education across three continents. He holds a master's in management from Harvard University and executive training from Harvard Kennedy School. A Pharm.D. graduate from the University of Colorado, he is a Certified Diabetes Educator, SCOPE-certified in obesity management, and holds Additional Prescribing Authority (APA). Zeyad serves as Lead Clinical Pharmacist at Cleveland Clinic Abu Dhabi and lectures at Imperial College London Abu Dhabi, Alameen University, and Alexandria University, contributing to the advancement of diabetes education and clinical practice.

International Speakers

Dr. Abdullah O. Al-Shehry

PharmD, MBA, BCPS

Director of Pharmacy, King Fahad Medical City Riyadh, KSA

Dr. Abdullah O. Al-Shehry

PharmD, MBA, BCPS

Dr. Alshehry earned his Bachelor of Pharmacy from King Saud University before beginning his career at King Fahad Medical City (KFMC) as a staff pharmacist, where he specialized in operations and automation services. He later pursued advanced education in the United States, completing both a Doctor of Pharmacy (PharmD) and a Master of Business Administration (MBA) at Long Island University in Brooklyn, NY. Following his graduate studies, Dr. Alshehry completed a PGY-1 Pharmacy Practice Residency at Houston Methodist Hospital, along with a Teaching and Scholarship in Academia Certificate from the University of Houston. His professional interests include optimizing healthcare outcomes, improving patient experience, enhancing pharmacy operations efficiency, and advancing pharmacist competency through the integration of pharmacoeconomics, automation, and evidence-based practice. In addition to his clinical and administrative roles, Dr. Alshehry has contributed to multiple published and unpublished clinical research projects and has served as an adjunct professor at the University of Houston. He currently serves as a Critical Care Clinical Pharmacist and Director of Pharmacy Services at KFMC, where he continues to lead initiatives that drive innovation, efficiency, and excellence in pharmacy practice.

Dr. Abdulrazaq S. Al-Jazairi

Pharm.D., MBA, FCCP, BCPS (AQ-Cardiology)

Director, Clinical Trials Transformation Initiative (CTTI) Division, King Faisal Specialist Hospital & Research Centre Riyadh, KSA

Dr. Abdulrazaq S. Al-Jazairi

Pharm.D., MBA, FCCP, BCPS (AQ-Cardiology)

Dr. Al-Jazairi is a Clinical Pharmacy Consultant in the field of Cardiovascular Pharmacotherapy, and the Director of the clinical Trials Transformation Division at the prestigious King Faisal Specialist Hospital and Research Center (KFSH&RC), Riyadh Saudi Arabia. He received his Doctor of Pharmacy degree from Campbell University at Buies Creek, North Carolina, USA, and a general Pharmacy Practice Residency at Duke University Medical Center (DUMC), Durham, NC. In 2000, Dr. Al-Jazairi completed a two-year Specialty Residency in Cardiovascular Pharmacotherapy from Philadelphia College of Pharmacy (PCP), University of the Sciences in Philadelphia in conjunction with the Hospital University of Pennsylvania (HUP), Philadelphia, Pennsylvania. More recently, 2014, Dr. Al-Jazairi earned a Master degree in Pharmaceutical and Healthcare Business from Mayes College, University of the Sciences in Philadelphia. Dr. Al-Jazairi is a board certified pharmacotherapy specialist with Cardiology added-qualification. Dr. Al-Jazairi has more than 50 original research publications, and delivered many national and international presentations. Dr. Al-Jazairi is the Founder of the Saudi Clinical Pharmacy Society, 2018. He is an editorial board member of prime journals, including Annals of Pharmacotherapy and the Annals of Saudi Medicine, for more than 15 years. He sets in several committees in Saudi-FDA, Saudi Commission for Health Specialties and Saudi Health Council. He is a member of the International Accreditation Commission, ASHP. Dr. Al-Jazairi enjoys training students and residents in Cardiology, Clinical Research and Evidence-based Medicine. Dr. AlJazairi is the Director of the first and only Cardiology Residency Program accredited by ASHP outside the States, at King Faisal Specialist Hospital and Research Center (KFSH&RC). He also serves as an Associate Professor, School of Pharmacy and School of Medicine in Alfaisal University, Qassim University, and adjunct Assistant Professor in Princess Nora University and member of the Advisory Board for College of Pharmacy

Dr. Anas Hamad

PhD, MSc, RPh

Director of Pharmacy Dept, NCCCR Head of Med Safety/Quality Center, HMC Head of Pharmacy Research Center, HMC Clinical Associate Professor, QU Lead of HTA Project, NHS, MOPH Head of Medications Committee, QRCS Vice President & Director, ISPOR Qatar

Dr. Anas Hamad

PhD, MSc, RPh

Dr. Anas is currently the Director of Pharmacy Department at Qatar's National Center for Cancer Care & Research. He is the Head of Medication Safety & Quality Center and Head of Pharmacy Research Center at Hamad Medical Corporation's Pharmacy Executive Office. He holds a position at Qatar University as a Clinical Associate Professor of Clinical Pharmacy & Practice. He is chairing the Standing Committee on Medication Services at Qatar Red Crescent Society. He is also the Vice President & Director of ISPOR Qatar Chapter. In addition, he is leading the Health Technology Assessment and Innovation Regulation Project under the National Health Strategy in the Ministry of Public Health. Dr. Anas finished his BSc in Pharmacy at the University of Jordan. He obtained MSc in Clinical Pharmacy, International Practice & Policy from the University of London and PhD in Clinical Practice & Medication Use from King's College London. He also acquired an Executive Diploma in Health Services Management from GSM London. Furthermore, he completed the Executive Leaders Program with Qatar Leadership Centre. That is in addition to multiple postgraduate certificates in health technology assessment, supply chain management, human subjects research, quality management, health economics and outcomes research. Dr. Anas is an active researcher with several publications and conference proceedings. He is an Editorial Board Member at International Journal of Clinical Pharmacy and Review Editor at Frontiers in Oncology. He regularly speaks at local and international conferences. He is a member of both HMC's and QU's Institutional Review Boards in addition to the MOPH National Clinical Research Review Committee. Moreover, he is a member of various committees/boards focusing on pharmacy practice, medication use, cancer care, research, safety & quality, medical affairs, healthcare education, health economics, governmental tenders, clinical transformation, and health insurance.

Dr. Courtney B. Smith

Medication Safety & Compliance Specialist Regulatory and Accreditation | Specialty Pharmacy Services Penn State Health Milton S. Hershey Medical Center Pennsylvania, USA

Dr. Courtney B. Smith

Dr. Courtney Smith is a specialty pharmacist at the Penn State Health Milton S. Hershey Medical Center. During her time at the health system, she worked under the pharmacy’s rheumatology service as a clinical pharmacist, where she leveraged her diverse background in both traditional and alternative medicine to provide comprehensive disease state management and specialty medication education. At Penn State Health, she emphasizes the importance of empowering patients through education and active participation in their treatment plans. She was recently promoted to the Medication Safety & Compliance Specialist role at the specialty pharmacy, guiding the team to meet all regulatory, accreditation and safety standards. In 2023, Dr. Smith received the Certified Specialty Pharmacist Certificant (CSP) and Board-Certified Medication Therapy Management Specialist (BCMTMS) designations. She is the recipient of the Upsher-Smith and NASPA Excellence in Innovation Award 2024, the Pennsylvania Pharmacists Association “Top Ten under Ten” Award 2024, the Pharmacy Podcasts – “Pharmacy 50” #28 and #26 Most Influential Pharmacy Leader for 2023 and 2024, and the National Association of Specialty Pharmacy (NASP) First Time Faculty Speaker 2023.

Dr. Jacob Jolly

PharmD, MMHC, CSP

Head of Pharmacy, Vaalia Health
Tennessee, USA

Dr. Jacob Jolly

PharmD, MMHC, CSP

Jacob Jolly is an experienced pharmacy leader with a deep background in the specialty pharmacy marketplace, health systems, and strategy. He currently serves as Head of Pharmacy at Vaalia Health, where he is building technology-enabled solutions to support specialty medication adherence. He is also the founder of ResonateRx, a consultancy supporting pharmacy and life sciences organizations. With previous leadership roles at Vanderbilt University Medical Center and Blue Fin Group, Jacob has broad and deep experiences to shape his perspective on innovative, patient-centered access solutions.

Dr. Jill Paslier

CEO and Founder of both Specia LLC and Paslier Consulting LLC
Pennsylvania, USA

Dr. Jill Paslier

Dr. Jill Paslier is a specialty pharmacy expert and the CEO and Founder of both Specia LLC and Paslier Consulting LLC. Specia LLC focuses on developing specialty pharmacy workflows and training programs, while Paslier Consulting LLC provides consulting services for specialty pharmacy operations, accreditation, and medication safety. She has provided expertise to organizations such as the Institute for Safe Medication Practices (ISMP), Integral Healthcare Solutions (IHS), and MetaStar. Dr. Paslier earned her Doctor of Pharmacy (PharmD) from the University of Minnesota College of Pharmacy in 2014 and completed the ISMP International Safe Medication Management Fellowship in 2021. She holds certifications in Medication Safety, Lean Six Sigma Green Belt, Certified Specialty Pharmacist (CSP), and Google Project Management.

Dr. Jonathan Ogurchak

PharmD, CSP, CPHIMS

CEO, Zeal Specialty Pharmacy;
CEO, STACK
Pittsburgh, USA

Dr. Jonathan Ogurchak

PharmD, CSP, CPHIMS

Jonathan Ogurchak, PharmD, CSP, CPHIMS has spent over 16 years of experience across specialty pharmacies, professional associations, and educational institutions. He is the CEO and co-founder of Zeal Specialty Pharmacy, an independent rare-disease pharmacy that leverages technology to deliver exceptional experiences for patients, prescribers, and pharmaceutical partners. Jonathan is also the CEO of STACK, a software company that offers two platforms: STACK for management of pharmacy resources and OnQueue, a pharmacy workflow and clinical management solution. Jonathan serves as an adjunct faculty member at 25 schools of pharmacy and contributes as a Director on the Specialty Pharmacy Certification Board (SPCB).

Dr. Kasem S. Akhras

PharmD

CEO and Co-Founder of VantEdge Acces Illinois, USA

Dr. Kasem S. Akhras

PharmD

Dr Kasem Akhras is CEO and Co-Founder of VantEdge Access, a healthcare start-up company bringing over 30 years of global biopharmaceutical experience in Market Access, pricing, Commercialization and artificial intelligence (AI). He has led strategic access and Government AMairs functions for top 10 pharma companies and advised on due diligence for multi-million-dollar deals. Kasem is a published author on Market Access in emerging markets, rare diseases, and Gene Therapy commercialization. His work bridges strategy, policy, and data science to expand global access to advanced therapies. He is passionate about leveraging AI to drive smarter, faster access decisions across diverse healthcare systems.

Dr. Mohamed Hashish

MSc, MS, BCPS, BCMTMS, RPh

Specialty Clinical Pharmacist (Cardiology | Hepatology | Neurology) Specialty Pharmacy, Cleveland Clinic, Ohio, USA

Dr. Mohamed Hashish

MSc, MS, BCPS, BCMTMS, RPh

Mohamed Hashish, MSc, MS, BCPS, BCMTMS, RPh is an international speaker and Specialty Pharmacist at Cleveland Clinic, USA, with over 15 years of cross-continental experience in the United States and the Middle East. He holds master’s degrees in Pharmaceutical Technology and Pharmacoeconomics & Health Economics, and is Board-Certified in Pharmacotherapy and Medication Therapy Management. Specializing in rare and complex disease states, Mohamed also serves as an advisor to ASHP’s Section of Specialty Pharmacy Practitioners, shaping strategies on patient care, outcomes, and value in specialty pharmacy.

Mr. Philip Morisky

MBA

Chief Optimus, Adherence Cartography
California, USA

Mr. Philip Morisky

MBA

Philip Morisky is a developer, researcher, and visionary whose work is redefining the future of patient-centered care. As the architect of the BAS-8™ and Behavioral Fragility Score (BFS), he has pioneered tools that bring predictive precision and stability modeling into medication adherence, bridging science with practical impact. A steward of his father’s legacy in the MMAS, he carries forward a tradition of innovation while advancing it into new domains of behavioral insight. His leadership has fueled successful ventures rooted in intellectual rigor, always centered on patients, as he continues to chart new frontiers in adherence research and practice.

Dr. Tariq Alzahrani

BSc. Pharm. BCOP

Consultant Oncology Clinical Pharmacist. Board Member, Saudi Society of Clinical Pharmacy Riyadh, KSA

Dr. Tariq Alzahrani

BSc. Pharm. BCOP

Tariq holds a bachelor's degree in pharmacy (2013), completed a PGY-1 and PGY-2 in oncology (2018–2021), and is Board Certified in Oncology Pharmacy (BCOP) by the Board of Pharmacy Specialties. With over 12 years of experience at King Faisal Specialist Hospital and Research Center, he currently works at the Saudi Food and Drug Authority. He also serves as a board member of the Saudi Society of Clinical Pharmacy, contributing to advancing clinical pharmacy practice in Saudi Arabia.

Moderators

Dr. Abdelgadir Elbatira Mohamed

Associate Director supply and Inventory, The Life Corner (TLC)
Abu Dhabi, UAE

Dr. Abdelgadir Elbatira Mohamed

Abdelgadir Elbatira is a distinguished healthcare leader with over 17 years of expertise in pharmacy practice, healthcare operations, and supply chain management across the UAE. He currently serves as Associate Director of Supply and Inventory at The Life Corner under PureHealth, where he directs commercial operations for SEHA pharmacies and drives strategies that strengthen patient care through sustainable supply and inventory systems.
Throughout his career, Abdelgadir has held senior leadership roles at leading institutions including Burjeel Hospital, Medeor 24/7 Hospital, NMC Specialty Hospital, and MOH facilities, where he successfully integrated pharmacy leadership with operational excellence and clinical outcomes. His work has consistently advanced regulatory compliance, procurement efficiency, and patient-centred medication-use systems. An active contributor to the professional community, Abdelgadir has participated in multiple local and international conferences, frequently sharing his expertise as a speaker on pharmacy leadership, supply chain resilience, and healthcare transformation. His ability to balance supply and inventory management with clinical and operational priorities reflects his broad impact across recognized healthcare groups.
Holding a Master’s degree in Pharmaceutics and a Mini MBA, Abdelgadir is widely respected for his strategic vision, leadership, and commitment to advancing healthcare delivery.

Dr. Belal Ahmad Hamad

Supply chain Manager , Dubai Health
Dubai, UAE

Dr. Belal Ahmad Hamad

Certified procurement – supply chain director, combining cross – functional competencies in Pharmacoeconomics, procurement and vendor management and quality in healthcare management. Expertise in project and procedures implementation, continuous improvement and change management to positively impact organizational goals. Proficient in identifying challenging areas and achieving corrective measures. Recognized by the executive team as dependable leader with ability to contribute as team player, coach and develop colleagues, and interface with professionals on all levels.

Dr. Jonathan Ogurchak

PharmD, CSP, CPHIMS

CEO, Zeal Specialty Pharmacy;
CEO, STACK
Pittsburgh, USA

Dr. Jonathan Ogurchak

PharmD, CSP, CPHIMS

Dr. Husam Majali

M.D, MCl.Sc

Market Access Manager Dubai, UAE

Dr. Husam Majali

M.D, MCl.Sc

Medical degree from the University of Jordan. Master of Health Economics from Barcelona school of management. Master of Clinical Science from Western University in Canada. Vast experience working with many leading Pharmaceutical companies and Medical Devices as Market Access Manager. Also worked with BUPA Health Insurance in Saudi Arabia in the role of Medical Manager.

Dr. Mohamed Baraka

PhD

Associate Professor of Clinical Pharmacy & Former Dean of Pharmacy at FCHS Abu Dhabi, UAE

Dr. Mohamed Baraka

PhD

Dr. Mohamed Baraka is a distinguished professor and thought leader in pharmacy practice, digital health innovation, and AI integration. With a strong background in healthcare technology and education, he actively shapes the future of pharmacy through research, teaching, and digital transformation. Expertise in Digital Health & AI • Certified in Applied Digital Health Ethics and Healthcare Delivery Value (DiMe) • Certified Trainer in Digital Health in Pharmacy Education (FIP) • Speaker at the 7th GCC eHealth Workforce Development Conference • Advocate for AI-driven clinical trials, digital therapeutics, and pharmacy automation • Expert in pharmacy informatics and AI-driven decision support systems Educational Innovation & Capacity Building • Pioneer in AI-enhanced pharmacy education and clinical decision-making tools • Contributor to international faculty development programs in digital health • Leader in OSCE development and pharmacy curriculum innovation • Co-developer of the FIP ‘Digital Health in Pharmacy’ course • Member of the IPE Taskforce for interdisciplinary healthcare education Current Focus Areas • AI integration in pharmacy education and practice • Digital therapeutics and patient engagement technologies • Pharmacy automation and informatics for improved patient care • Faculty and workforce development in digital health education Dr. Baraka remains dedicated to advancing pharmacy practice through innovation, research, and digital transformation, ensuring the next generation of pharmacists is equipped for the evolving healthcare landscape. Current interests include exploring the intersection of artificial intelligence and pharmacy practice, advancing digital health implementation in healthcare delivery, and developing innovative approaches to pharmacy education in the digital age

Dr. Mohamed Hashish

MSc, MS, BCPS, BCMTMS, RPh

Specialty Clinical Pharmacist (Cardiology | Hepatology | Neurology) Specialty Pharmacy, Cleveland Clinic, Ohio, USA

Dr. Mohamed Hashish

MSc, MS, BCPS, BCMTMS, RPh

Dr. Nour Kassem

RPh, PGD, MSc(c)

Research Scholar
Cleveland Clinic Abu Dhabi

Dr. Nour Kassem

RPh, PGD, MSc(c)

Dr. Nour Kassem is a registered pharmacist and clinical researcher with advanced training in data science and clinical research. She focuses on expanding access to specialty medicines and reducing patients’ financial burden through innovative, evidence-based solutions. With a passion for bridging pharmacy, technology, and research, Dr. Nour develops strategies that enhance patient experience, improve treatment adherence, and promote health equity. She is dedicated to advancing the specialty pharmacy field in the region by driving research and innovation that shape sustainable, patient-centered models of care.